Switch theme
Sign up to access all valuation multiples
Lifecare ASA focuses on the research, development, and commercialization of sensor technology for continuous monitoring of body analytes. Lifecare develops and licenses nanotechnology for medical use to facilitate the production and sale of medical devices. Its miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber, and can, e.g., measure glucose and lactate levels by applying different chemical compositions. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
2006
39
LTM Revenue $0.6M
LTM EBITDA -$7.4M
$8.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Lifecare has a last 12-month revenue (LTM) of $0.6M and a last 12-month EBITDA of -$7.4M.
In the most recent fiscal year, Lifecare achieved revenue of $0.3M and an EBITDA of -$6.7M.
Lifecare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Lifecare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $0.6M | XXX | $0.3M | XXX | XXX | XXX |
| Gross Profit | $0.5M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 80% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$7.4M | XXX | -$6.7M | XXX | XXX | XXX |
| EBITDA Margin | -1179% | XXX | -2247% | XXX | XXX | XXX |
| EBIT | -$7.9M | XXX | -$8.3M | XXX | XXX | XXX |
| EBIT Margin | -1253% | XXX | -2797% | XXX | XXX | XXX |
| Net Profit | -$7.2M | XXX | -$7.0M | XXX | XXX | XXX |
| Net Margin | -1143% | XXX | -2367% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Lifecare's stock price is NOK 7 (or $1).
Lifecare has current market cap of NOK 115M (or $11.3M), and EV of NOK 84.7M (or $8.3M).
See Lifecare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.3M | $11.3M | XXX | XXX | XXX | XXX | $-0.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Lifecare has market cap of $11.3M and EV of $8.3M.
Lifecare's trades at 27.9x EV/Revenue multiple, and -1.2x EV/EBITDA.
Equity research analysts estimate Lifecare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lifecare has a P/E ratio of -1.6x.
See valuation multiples for Lifecare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $11.3M | XXX | $11.3M | XXX | XXX | XXX |
| EV (current) | $8.3M | XXX | $8.3M | XXX | XXX | XXX |
| EV/Revenue | 13.1x | XXX | 27.9x | XXX | XXX | XXX |
| EV/EBITDA | -1.1x | XXX | -1.2x | XXX | XXX | XXX |
| EV/EBIT | -1.0x | XXX | -1.0x | XXX | XXX | XXX |
| EV/Gross Profit | 16.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.6x | XXX | -1.6x | XXX | XXX | XXX |
| EV/FCF | -1.1x | XXX | -1.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLifecare's last 12 month revenue growth is 146%
Lifecare's revenue per employee in the last FY averaged $8K, while opex per employee averaged $0.2M for the same period.
Lifecare's rule of 40 is -787% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lifecare's rule of X is -812% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Lifecare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 146% | XXX | 193% | XXX | XXX | XXX |
| EBITDA Margin | -1179% | XXX | -2247% | XXX | XXX | XXX |
| EBITDA Growth | -21% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -787% | XXX | -2100% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -812% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 642% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 2897% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lifecare acquired XXX companies to date.
Last acquisition by Lifecare was XXXXXXXX, XXXXX XXXXX XXXXXX . Lifecare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Lifecare founded? | Lifecare was founded in 2006. |
| Where is Lifecare headquartered? | Lifecare is headquartered in Norway. |
| How many employees does Lifecare have? | As of today, Lifecare has 39 employees. |
| Is Lifecare publicy listed? | Yes, Lifecare is a public company listed on OSL. |
| What is the stock symbol of Lifecare? | Lifecare trades under LIFE ticker. |
| When did Lifecare go public? | Lifecare went public in 2018. |
| Who are competitors of Lifecare? | Similar companies to Lifecare include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Lifecare? | Lifecare's current market cap is $11.3M |
| What is the current revenue of Lifecare? | Lifecare's last 12 months revenue is $0.6M. |
| What is the current revenue growth of Lifecare? | Lifecare revenue growth (NTM/LTM) is 146%. |
| What is the current EV/Revenue multiple of Lifecare? | Current revenue multiple of Lifecare is 13.1x. |
| Is Lifecare profitable? | Yes, Lifecare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lifecare? | Lifecare's last 12 months EBITDA is -$7.4M. |
| What is Lifecare's EBITDA margin? | Lifecare's last 12 months EBITDA margin is -1179%. |
| What is the current EV/EBITDA multiple of Lifecare? | Current EBITDA multiple of Lifecare is -1.1x. |
| What is the current FCF of Lifecare? | Lifecare's last 12 months FCF is -$7.4M. |
| What is Lifecare's FCF margin? | Lifecare's last 12 months FCF margin is -1168%. |
| What is the current EV/FCF multiple of Lifecare? | Current FCF multiple of Lifecare is -1.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
